Why Teva Pharmaceutical Is Crashing Today
After the company provided investors with yet another disappointing update to its financial performance, shares in Teva Pharmaceutical (NYSE: TEVA) are losing 15% as of 1 p.m. EDT.
It's been tough going in 2017 for the world's biggest generic drugmaker, and unfortunately, investors hoping that the worst was behind the company earlier this year may have to settle in and expect some more rockiness.
IMAGE SOURCE: GETTY IMAGES.
Source: Fool.com